Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fnins.2017.00329 http://scihub22266oqcxt.onion/10.3389/fnins.2017.00329 C5461286!5461286!28638319     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Neurosci 2017 ; 11 (ä): ä Nephropedia Template TP {{tp|p=28638319|t=2017. Dynamiceuticals: The Next Stage in Personalized Medicine |pdf=|usr=}}{{28638319}} gab.com Text Dynamiceuticals: The Next Stage in Personalized Medicine JO: Front Neurosci http://www.kidney.de/pget.php?&tw=1&pmid=28638319 #FOAvip The surge in the interest in personalized medicine necessitates a corresponding rational approach for implementing such individualized therapies. Dynamiceuticals represents a natural extension of the Pharmaceutical and Electroceutical fields, where the precise determination of the dynamical regimes of the pathophysiology will guide to devise therapies that ameliorate the pathology in a well-controlled manner, thus being precisely tailored toward the implementation of individualized medicine. This approach foretells to lessen side-effects and achieve superior efficacy as compared with current trial-and-error or open-loop strategies. But does the current state of knowledge and technology allow this scheme to offer what it claims? Twit Text FOAVip Dynamiceuticals: The Next Stage in Personalized Medicine ????Front Neurosci http://www.kidney.de/pget.php?&tw=1&pmid=28638319 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28638319 #FOAvip English Wikipedia <ref>{{Cite pmid|28638319}}</ref> Dynamiceuticals: The Next Stage in Personalized Medicine #MMPMID28638319 Perez Velazquez JL Front Neurosci 2017[]; 11 (ä): ä PMID28638319show ga The surge in the interest in personalized medicine necessitates a corresponding rational approach for implementing such individualized therapies. Dynamiceuticals represents a natural extension of the Pharmaceutical and Electroceutical fields, where the precise determination of the dynamical regimes of the pathophysiology will guide to devise therapies that ameliorate the pathology in a well-controlled manner, thus being precisely tailored toward the implementation of individualized medicine. This approach foretells to lessen side-effects and achieve superior efficacy as compared with current trial-and-error or open-loop strategies. But does the current state of knowledge and technology allow this scheme to offer what it claims? äDynamiceuticals: The Next Stage in Personalized Medicine (epmc).pdf DeepDyve Pubget Overpricing